Djokovic buys Danish company developing Covid-19 treatment

Alisa Barladyan
19 Jan 2022
Djokovic buys Danish company developing Covid-19 treatment

Serbian tennis player Novak Djokovic has bought an 80% in a Danish biotechnology company that is developing a cure for the coronavirus.

The information was confirmed by the executive director of the company.

Previously, Djokovic opposed the compulsory vaccination against COVID-19. At the beginning of 2022, the athlete could not take part in the Australian Open. He arrived in Melbourne, but Australian authorities detained him because of problems with his medical clearance documents, revoked his visa, and sent him to quarantine. The court's decision, initially overturned on appeal, was later upheld, so Djokovic had to leave the country a few days later.

This website uses cookies
This provides customers with a personalized experience and increases the efficiency of visiting the site, allowing us to provide the most efficient service. By using the website and accepting the terms of the policy, you consent to the use of cookies in accordance with the terms of this policy.